COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,731 Articles (22,502 medRxiv, 8,229 bioRxiv)

Most recent first Previous |  Page 1225: Articles 12241-12250  | Next

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalized patients with COVID-19: A network meta-analysis
Godolphin, P. J., Fisher, D. J., Berry, L. R., Derde, L. P., Diaz, J. V., Gordon, A. C., Lorenzi, E., Marshall, J. C., Murthy, S., Shankar-Hari, M., Sterne, J. A., Tierney, J. F., Vale, C. L.
10.1101/2021.08.26.21262523 — Posted: 2021-08-28
Effectiveness of vaccination against symptomatic and asymptomatic SARS-CoV-2 infection: a systematic review and meta-analysis
Meggiolaro, A., Sane Schepisi, M., Nikolaidis, G., Mipatrini, D., Siddu, A., Rezza, G.
10.1101/2021.08.25.21262529 — Posted: 2021-08-28
Profile of Mucormycosis Cases from a Network of Hospitals in North India Amidst COVID-19 Pandemic
Budhiraja, S., Aggarwal, M., Mahajan, M., Indrayan, A., Jha, V., Mithal, A., Sachdeva, S., Mrig, S., Jain, A., Gera, R., Aggarwal, R., Kalra, S., Ramalingam, W., Deka, A., Dass, A., Jijina, D., ManSingh, A., Singhal, A., Reddi, R., Aggarwal, P., Kumar, M., Mukherji, J. D., Nangia, V., Lall, A., Singh, O., Dewan, A., Jain, A., Shrivastava, G. G., Bhattacharjee, M., Nihalani, M., Kumar, M., Jain, M., Mehra, M., Arora, V., Mehta, V. P., Bhalla, D., Batra, A., Gupta, R., Kumar, V., Dua, S., Pandey, P., Singh, Y. P., Mathur, M., Singh, A., Arora, S., Gupta, A. K., Choudhary, P. N., Singh, M., Kaul, N., Pathak, S. P., Joshi, S., Gupta, M., Mishra, R., Joshi, A., Aggarwal, M., Gupta, R., Boobna, V., Chhabra, Y. K., Chugh, I. M., Garg, S., Mittal, V., Sood, N., Kumar, A., Pande, R. K., Singh, V. P., Khan, I., Garg, N., Belwal, S., Tyagi, P., Roy, A. K., Bhasin, D., Pandove, S., Bahl, R., Soni, P.
10.1101/2021.08.25.21262404 — Posted: 2021-08-28
Implementation of a Web-Based Symptom Checker to Manage the Quarantine of the USS Theodore Roosevelt Crew Following a Shipboard Outbreak of SARS-CoV-2
Fenequito, R. L., Houskamp, D., Siu, V., Rorie, J., Bhatt, N., Kuang, M., Luartes, B., Shell, D., Reeder, J., Rainey, K., Olson, N.
10.1101/2021.08.25.21254738 — Posted: 2021-08-28
Socioeconomic and comorbid factors affecting mortality and length of stay in COVID-19
Delora, A., Mills, A., Jacobson, D., Cornett, B., Peacock, W. F., Datta, A., Jenks, S.
10.1101/2021.08.26.21262693 — Posted: 2021-08-28
History of suicide attempts and COVID-19 infection in Veterans with schizophrenia or schizoaffective disorder: effect modification by age and obesity
Okusaga, O. O., Kember, R. L., Peloso, G. M., Peterson, R. E., Vujkovic, M., Mitchell, B. G., Bernard, J., Walder, A., Bigdeli, T. B.
10.1101/2021.08.25.21262627 — Posted: 2021-08-28
Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
Velasquez Garcia, H. A., Wilton, J., Smolina, K., Chong, M., Rasali, D., Otterstatter, M., Rose, C., Prystajecky, N., David, S., Galanis, E., McKee, G., Krajden, M., Janjua, N. Z.
10.1101/2021.08.26.21262697 — Posted: 2021-08-28
Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021
Cheng, C.-J., Lu, C.-Y., Chang, Y.-H., Sun, Y., Chu, H.-J., Lee, C.-Y., Liu, C.-H., Lin, C.-H., Lu, C.-J., Li, C.-Y.
10.1101/2021.08.23.21262500 — Posted: 2021-08-28
Effect of losartan on hospitalized patients with COVID-19-induced lung injury: A randomized clinical trial
Puskarich, M. A., Ingraham, N. E., Merck, L. H., Driver, B. E., Wacker, D. A., Black, L. P., Jones, A. E., Fletcher, C. V., South, A. M., Nelson, A. C., Murray, T. A., Lewandowski, C., Farhat, J., Benoit, J. L., Bryne, D., Hall, A., Reilkoff, R. A., Biros, M. H., Cherabuddi, K., Chipman, J. G., Schacker, T. W., Bold, T., Beckman, K. B., Langlois, R., Aliota, M., Guirgis, F., Galbraith, J., Beyer, M., Salmen, C., Roberts, B. W., Wright, D. W., Voelker, H., Koopmeiners, J. S., Tignanelli, C. J.
10.1101/2021.08.25.21262623 — Posted: 2021-08-28 Discussion: Onsite
Erytra Blood Group Analyser and Kode Technology testing of SARS-CoV-2 antibodies among convalescent patients and vaccinated individuals
Weinstock, C., Flegel, W. A., Srivastava, K., Kaiser, S., Schrezenmeier, H., Tsamadou, C., Ludwig, C., Jahrsdoerfer, B., Bovin, N. V., Henry, S. M.
10.1101/2021.08.26.21262219 — Posted: 2021-08-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).